Hospital-acquired Infection Control Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Hospital-acquired Infection Control Market size is projected to experience significant growth from 2019 to 2025.
 

Hospital-acquired infection control market will witness considerable growth in the forecast period due to the rising incidence of various types of hospital-acquired infections such as pneumonia, surgical site infections, bloodstream infections and urinary tract infection. According to the Centers for Disease Control and Prevention (CDC), in the U.S., about 1.7 million hospitalized patients acquire healthcare-associated infections (HCAIs) annually. Thus, increasing prevalence of hospital-acquired infections will create significant demand for hospital-acquired infection control market in the estimation period.
 

Increase in hospital stay due to chronic diseases and surgeries will augment the global hospital-acquired infection control market business growth in the coming years. According to the World Health Organization (WHO), among 100 hospitalized patients, 7 in developed and 10 in developing nations are estimated to acquire at least one HCAI. Additionally, due to the poor conditions in a hospital and the patient’s weak immune system, these infections prevail at a rapid speed than the normal infections. Aforementioned mentioned factors will offer lucrative growth opportunities for hospital-acquired infection control market over the forthcoming years.
 

However, presence of stringent regulatory policies concerning to hospital-acquired infection control procedures will restrain market growth to some extent. Furthermore, saturation due to extensive usage of infection control agents in developed economies will hinder growth in these regions.
 

Disinfectants segment is expected to hold maximum revenue share over the forecast period. Most hospitals use disinfectants for achieving excellent environmental hygiene in hospital rooms. Usage of disinfected medical equipment can further prevent spreading of infections. Moreover, large scale usage of a number of disinfectants across the healthcare industry will drive segmental growth over the forthcoming years.
 

Hospital segment will show momentous growth over the projected timeframe due to the increasing number of surgical procedures and growing prevalence of nosocomial infections. Growing frequency of in-patient surgical treatments will increase the length of hospital stay, thereby increasing the demand for hospital-acquired infection control market. Additionally, availability of upgraded healthcare infrastructure to treat various chronic diseases will drive the segmental growth.
 

U.S. hospital-acquired infection control market is estimated to witness lucrative growth over the forecast period. Aging geriatric population results in exposure of various chronic diseases thus, boosting the regional market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in the U.S., about 1 in 31 hospitalized patients are suffering from at least one HCAI. Moreover, rising prevalence of nosocomial infections coupled with growing awareness levels amongst the public as well as healthcare practitioners will drive the hospital-acquired infection control industry growth in the country.
 

India hospital-acquired infection control market will show significant growth during the projected timeframe owing to growing incidence of various chronic diseases that require persistent infection control techniques. Vast elderly population act as a major growth factor for hospital-acquired infection control procedures in the country. Thus, in low- and middle-income countries such as India the frequency of intensive care units (ICU)-acquired infection is at least 2?3 times higher than in high-income countries.
 

Some of the major players operating in the global hospital-acquired infection control market include Olympus, Medivators Inc. (Cantel Medical), Getinge AB, Steris plc. and Belimed among other players. These industry players implement various strategic initiatives such as new product launches, partnerships, collaborations, mergers & acquisitions to enhance financial stability and company growth. For instance, in August 2017, Cantel Medical acquired BHT Group, a leading German company involved in the manufacturing of automated endoscope reprocessors, washer disinfectors, and related services. This strategy will strengthen the company’s market position. 
 

Hospital-acquired Infection Control Market by Product, 2014-2025 (USD Million)

• Sterilizers
  • Heat sterilization equipment
  • Low temperature sterilization equipment
  • Radiation sterilization equipment
  • Others
• Disinfectants
  • Hand disinfectants
  • Skin disinfectants
  • Instrument disinfectants
  • Others
• Endoscope reprocessors
• Others

Hospital-acquired Infection Control Market by End-use, 2014-2025 (USD Million)

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Nursing Homes and Maternity Centers
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East and Africa
  • South Africa
  • Saudi Arabia

Company Profiles:

• Olympus
• Medivators Inc. (Cantel Medical)
• Getinge AB
• Steris plc.
• Belimed
• F. Hoffmann-La Roche Ltd
• Abbott
• 3M
• Cepheid
• Ecolab

What Information does this report contain?